GlassScriptPhysician profile
Ruth Strakosha
NPI 1871911941
$6,747.01
in general payments reported to CMS, 2019-2025
48 companies · $1,693 in 2025
The $1,693 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $684 · 2021: $857 · 2022: $841 · 2023: $1,392 · 2024: $986 · 2025: $1,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,750 · Travel and Lodging: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,750.07 |
| Travel and Lodging | $321.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,070.94 | 2019-2025 | Axonics, Lithovue, Tria Firm |
| Axonics, INC. | $888.43 | 2020-2024 | Axonics |
| Coloplast Corp | $654.47 | 2020-2025 | Speedicath |
| Sumitomo Pharma America, INC. | $551.79 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $384.41 | 2020-2024 | Prolaris, Myrisk |
| Ferring Pharmaceuticals INC. | $377.33 | 2024-2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $318.22 | 2020-2023 | Xiaflex, Aveed |
| Astellas Pharma US INC | $267.42 | 2020-2023 | Myrbetriq |
| Abbvie INC. | $263.22 | 2022-2025 | Botox, Lupron Depot |
| Allergan, INC. | $188.81 | 2020-2021 | |
| Urogen Pharma, INC. | $128.50 | 2023-2025 | Jelmyto |
| Procept Biorobotics Corporation | $124.77 | 2024-2025 | Aquabeam System |
| Teleflex LLC | $124.02 | 2021-2025 | Urolift, Barrigel |
| Pfizer INC. | $110.93 | 2020-2025 | |
| Myovant Sciences INC. | $92.29 | 2021-2022 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $80.23 | 2022-2023 | Gentlecath |
| Merck Sharp & Dohme LLC | $75.50 | 2022-2023 | Keytruda, Lynparza, Welireg |
| Laborie Medical Technologies Corp. | $74.87 | 2022-2024 | Endosheath Technology, Urgent PC Neuromodulation System |
| Blue Earth Diagnostics | $73.66 | 2023-2025 | Posluma |
| Dentsply Ih Ab | $71.90 | 2023-2024 | Lofric, Lofric |
| Medtronic, INC. | $71.61 | 2021-2024 | Interstim |
| Accord Healthcare, INC. | $57.60 | 2022 | |
| Janssen Biotech, INC. | $55.20 | 2019 | |
| Calyxo, INC. | $53.48 | 2025 | Cvac Aspiration System |
| Novartis Pharmaceuticals Corporation | $49.35 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $42.23 | 2020-2021 | |
| Medtronic USA, INC. | $37.31 | 2020 | |
| Acerus Pharmaceuticals Corporation | $33.55 | 2020-2021 | |
| Dentsply Ih INC. | $33.38 | 2020-2021 | |
| Olympus America INC. | $31.64 | 2020-2023 | Itind System |
| Verity Pharmaceuticals INC. | $30.53 | 2024 | Trelstar |
| Baxter Healthcare | $29.74 | 2023 | Tisseel |
| Janssen Scientific Affairs, LLC | $27.64 | 2025 | Pipeline, Erleada |
| Endo USA, INC. | $23.59 | 2025 | Xiaflex |
| Immunitybio, INC. | $22.85 | 2025 | |
| Guard Medical INC. | $21.37 | 2025 | Npseal |
| C. R. Bard, INC. & Subsidiaries | $20.97 | 2020 | |
| Bluewind Medical | $20.94 | 2025 | |
| Hollister Incorporated | $19.73 | 2023 | Onli |
| Bayer Healthcare Pharmaceuticals INC. | $18.85 | 2022 | |
| Cycle Pharmaceuticals INC | $18.11 | 2025 | Venxxiva |
| Neotract INC. | $17.70 | 2020 | |
| Urovant Sciences INC | $17.35 | 2022 | |
| Ambu INC. | $17.06 | 2025 | |
| Conmed Corporation | $15.68 | 2025 | Airseal |
| Abc Home Medical Supply, INC. | $15.42 | 2023 | |
| Antares Pharma, INC. | $13.24 | 2021 | |
| Clarus Therapeutics INC. | $9.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Strakosha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.